Correlation Between Sangamo Therapeutics and Celldex Therapeutics
Can any of the company-specific risk be diversified away by investing in both Sangamo Therapeutics and Celldex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sangamo Therapeutics and Celldex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sangamo Therapeutics and Celldex Therapeutics, you can compare the effects of market volatilities on Sangamo Therapeutics and Celldex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sangamo Therapeutics with a short position of Celldex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sangamo Therapeutics and Celldex Therapeutics.
Diversification Opportunities for Sangamo Therapeutics and Celldex Therapeutics
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Sangamo and Celldex is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Sangamo Therapeutics and Celldex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Celldex Therapeutics and Sangamo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sangamo Therapeutics are associated (or correlated) with Celldex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Celldex Therapeutics has no effect on the direction of Sangamo Therapeutics i.e., Sangamo Therapeutics and Celldex Therapeutics go up and down completely randomly.
Pair Corralation between Sangamo Therapeutics and Celldex Therapeutics
Given the investment horizon of 90 days Sangamo Therapeutics is expected to under-perform the Celldex Therapeutics. In addition to that, Sangamo Therapeutics is 1.67 times more volatile than Celldex Therapeutics. It trades about -0.13 of its total potential returns per unit of risk. Celldex Therapeutics is currently generating about -0.16 per unit of volatility. If you would invest 2,454 in Celldex Therapeutics on November 27, 2024 and sell it today you would lose (208.00) from holding Celldex Therapeutics or give up 8.48% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sangamo Therapeutics vs. Celldex Therapeutics
Performance |
| Timeline |
| Sangamo Therapeutics |
| Celldex Therapeutics |
Sangamo Therapeutics and Celldex Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sangamo Therapeutics and Celldex Therapeutics
The main advantage of trading using opposite Sangamo Therapeutics and Celldex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sangamo Therapeutics position performs unexpectedly, Celldex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celldex Therapeutics will offset losses from the drop in Celldex Therapeutics' long position.| Sangamo Therapeutics vs. Editas Medicine | Sangamo Therapeutics vs. Intellia Therapeutics | Sangamo Therapeutics vs. Bluebird bio | Sangamo Therapeutics vs. Alnylam Pharmaceuticals |
| Celldex Therapeutics vs. Ideaya Biosciences | Celldex Therapeutics vs. AnaptysBio | Celldex Therapeutics vs. MeiraGTx Holdings PLC | Celldex Therapeutics vs. Keros Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |